Search for: "TEVA USA, INC."
Results 621 - 640
of 646
Sorted by Relevance
|
Sort by Date
20 Jun 2018, 5:00 pm
Teva Pharmaceuticals USA Inc., 17-1229, the bar section will be completely full on the day it is argued. [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition:… [read post]
23 Apr 2014, 8:50 am
Owens, 13-719 (granted at the April 4 Conference, relisted once); Teva Pharmaceuticals USA, Inc. v. [read post]
21 May 2019, 6:18 am
They can be “subsumed within an already tightly circumscribed legal analysis,” as the court recently explained in the patent-construction context in Teva Pharmaceuticals USA Inc. v. [read post]
Celanese v. ITC: Can a Secret Manufacturing Process Be Patented After Sale of the Resulting Product?
4 Mar 2024, 9:45 am
Teva Pharmaceuticals USA, Inc. held that in the AIA, Congress did not change the meaning of “on sale” from the pre-AIA statute. [read post]
22 Jan 2009, 2:06 am
Wyeth, Inc., 168 Cal. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
3 Apr 2014, 2:49 pm
The petitioners in the patent-infringement case Teva Pharmaceuticals USA, Inc. v. [read post]
8 Aug 2018, 1:51 pm
The current Supreme Court is friendly toward big business. [read post]
18 May 2023, 8:01 am
Most surprisingly to me, the court denied review in Teva Pharmaceuticals USA, Inc. v. [read post]
10 Feb 2023, 4:44 am
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
2 Mar 2012, 6:52 am
Bard, Inc. [read post]
9 Aug 2012, 5:00 am
Bard, Inc. [read post]
30 Mar 2022, 7:56 am
Vizio, Inc., 2022 WL 885771 (Fed. [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
5 Jul 2008, 11:05 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
12 Jun 2023, 1:09 pm
In Matrixx Initiatives, Inc. v. [read post]
15 Oct 2018, 7:05 am
This week the Court released the calendar for arguments at the end of November and into December these cases are: Apple, Inc. v. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
11 Apr 2008, 9:00 am
’ – 18 – 22 June, US/Alaska: (Public Knowledge), Center for IP 8th Annual IP Symposium – 28-30 May, Maryland US: (Public Knowledge), University of Maastricht: Conference on public health, innovation and intellectual property – 15 April, Maastricht (Netherlands): (IPR-Helpdesk), NLSIU Symposium: ‘Challenges to India’s patent regime’ – 12-13 April: (Spicy IP), Anti-counterfeiting and brand… [read post]
